FRIDAY, Aug. 24 (HealthDay News) -- Stent fracture is one of the most common causes of in-stent restenosis in patients with sirolimus-eluting stents, according to a report in the Aug. 15 issue of the American Journal of Cardiology.
Sang-Hee Lee, M.D., of Yeung-nam University Hospital in Daegu, Korea, and colleagues analyzed findings from 366 patients who had received sirolimus-eluting stents and had later returned for follow-up angiography.
The investigators found that 26 patients had developed in-stent restenosis. Out of this group, the researchers discovered stent fractures in 10 patients. Five patients had an avulsion-type fracture (defined as two fractured segments completely separated, or stent struts missing from the fracture site); two patients had collapse fracture (folded and compacted stent walls in a bended segment of the device) and three had partial fracture (missing stent struts in at least one-third of the vessel wall).
"We cannot conclude that any one factor is the key element for stent fracture after sirolimus-eluting stent implantation. However, we speculate that multiple factors, including poor neointimal hyperplasia, stent design and cardiac movement, contribute to the development of stent fracture," the authors write.
Abstract
Full Text (subscription or payment may be required)
